Charles Yonan

PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury

Flora M. Hammond, David N. Alexander, Andrew J. Cutler et al. · BMC Neurology · 2016 · 36 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +17

An open-label study to assess safety, tolerability, and effectiveness of dextromethorphan/quinidine for pseudobulbar affect in dementia: PRISM II results

Rachelle S. Doody, Stephen D’Amico, Andrew J. Cutler et al. · CNS Spectrums · 2015 · 13 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

Clinician Perceptions of the Negative Impact of Telehealth Services in the Management of Drug-Induced Movement Disorders and Opportunities for Quality Improvement: A 2021 Internet-Based Survey

Rimal Bera, Morgan Bron, Betsy Benning et al. · Neuropsychiatric Disease and Treatment · 2022 · 11 citations · Full text

Medicine, Pharmacology, Psychiatry +13

Prevalence of pseudobulbar affect symptoms and clinical correlates in nursing home residents

Kevin T. Foley, R. Tamara Konetzka, Anthony Bunin et al. · International Journal of Geriatric Psychiatry · 2015 · 10 citations · Full text

Medicine, Neurology, Psychiatry +9

Identification of pseudobulbar affect symptoms in Veterans with possible traumatic brain injury

Jennifer R. Fonda, Phillip R. Hunt, Regina E. McGlinchey et al. · The Journal of Rehabilitation Research and Development · 2015 · 10 citations

Medicine, Neurology, Psychiatry +15